NCT02972996

Brief Summary

Lifestyle strategies that include dietary modification, such as consumption of a plant-based diet, are well recognized in disease prevention and may improve type 2 diabetes. Various components of a plant-based diet may contribute to its beneficial health effects, but there has been keen interest in the possibility that plant polyphenols may have a role. Blueberries are dietary sources of polyphenols, specifically anthocyanins. To date there are few human clinical trials evaluating the beneficial health effects of blueberries in populations with type 2 diabetes. The objective of the study is to determine if freeze-dried blueberries compared to a blueberry placebo will improve cardiometabolic parameters in men with type 2 diabetes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 22, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 25, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

January 19, 2017

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 21, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 21, 2018

Completed
3.8 years until next milestone

Results Posted

Study results publicly available

April 19, 2022

Completed
Last Updated

April 19, 2022

Status Verified

February 1, 2022

Enrollment Period

1.4 years

First QC Date

November 22, 2016

Results QC Date

October 1, 2019

Last Update Submit

February 17, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Blood Pressure

    Systolic blood pressure and diastolic blood pressure.

    8 weeks

Secondary Outcomes (1)

  • Hemoglobin A1C

    8 weeks

Study Arms (2)

Blueberry

EXPERIMENTAL

22 g freeze-dried blueberries

Other: Blueberry

Placebo

PLACEBO COMPARATOR

22 g placebo

Other: Placebo

Interventions

22 g freeze-dried whole blueberry powder

Blueberry
PlaceboOTHER

22 g placebo blueberry powder

Placebo

Eligibility Criteria

Age45 Years - 75 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male
  • Ages 45 to 75 years at beginning of study
  • BMI \>25 kg/m2
  • HbA1C \> 6.5 and \< 9
  • Medical diagnosis of type 2 diabetes for at least 6 months

You may not qualify if:

  • Use of insulin
  • Presence of chronic kidney disease (GFR \< 45 mL/min), liver cirrhosis, gastrointestinal disease, pancreatic disease, or malabsorption syndromes
  • Weight loss of \>10% of body weight over the last 6 months; routine participation in heavy exercise
  • Heavy smokers (\>20 cigarettes per day)
  • Unable or unwilling to give informed consent or communicate with study staff
  • Other medical, psychiatric, or behavioral factors that in the judgment of the Principal Investigators may interfere with study participation or the ability to follow the intervention protocol
  • Allergies to blueberries or blueberry products

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stratton V.A. Medical Center

Albany, New York, 12208, United States

Location

Related Publications (1)

  • Stote KS, Wilson MM, Hallenbeck D, Thomas K, Rourke JM, Sweeney MI, Gottschall-Pass KT, Gosmanov AR. Effect of Blueberry Consumption on Cardiometabolic Health Parameters in Men with Type 2 Diabetes: An 8-Week, Double-Blind, Randomized, Placebo-Controlled Trial. Curr Dev Nutr. 2020 Mar 9;4(4):nzaa030. doi: 10.1093/cdn/nzaa030. eCollection 2020 Apr.

MeSH Terms

Interventions

blueberry extract

Results Point of Contact

Title
Margaret M. Wilson MS, RD, LD/N, CD/N, CNSC, CDE
Organization
Stratton V.A. Medical Center

Study Officials

  • Margaret M. Wilson, MS, RD, CDE

    Stratton V.A. Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 22, 2016

First Posted

November 25, 2016

Study Start

January 19, 2017

Primary Completion

June 21, 2018

Study Completion

June 21, 2018

Last Updated

April 19, 2022

Results First Posted

April 19, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations